Join us for this Science Talk with Drs. Ali Salanti, Max M Søgaard, and Louise Leth Hefting on development of a virus-like particle (VLP)-based COVID-19 vaccine and what the companies behind it, AdaptVac and ExpreS2ion Biotechnologies, have done to fast-track their developmental pipeline.

Presenter:

  • Max M Søgaard, PhD, Vice President at ExpreS2ion Biotechnologies ApS.
  • Ali Salanti, PhD, Professor of Translational Microbiology; Co-Founder & Board Member at AdaptVac ApS
  • Louise Leth Hefting, PhD, Field Application Scientist at ChemoMetec A/S
  • Janny Marie L Peterslund, PhD, Scientific Affairs Manager at ChemoMetec A/S

Join us for this Science Talk with Drs. Ali Salanti, Max M Søgaard, and Louise Leth Hefting on development of a virus-like particle (VLP)-based COVID-19 vaccine and what the companies behind it, AdaptVac and ExpreS2ion Biotechnologies, have done to fast-track their developmental pipeline.

In this science talk you’ll learn:

  • Learn about the capsid VLP and ExpreS2™ technologies
  • Get the insights on fast-tracking a COVID-19 vaccine
  • What did AdaptVac and EspreS2ion learn through this developmental work?
  • How did they work with industry partner ChemoMetec?
  • What are Salanti and Søgaard’s take on the COVID-19 vaccine landscape?

Duration: 36 minutes